MOLECULIN BIOTECH INC (MBRX:NASDAQ)

$2.73 0.28 (11.4286%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 66

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed MOLECULIN BIOTECH INC (MBRX:NASDAQ) News Sources

Moleculin Hits 45 Subject Enrollment Milestone, Triggering Final Countdown to Mid-2026 MIRACLE Trial Data Readout

23-03-2026

yahoo.com

Moleculin Releases Next CEO Corner Segment Highlighting Annamycin’s Non-Cardiotoxic Profile

07-04-2026

yahoo.com

Moleculin Announces Abstract Accepted for Poster Presentation at the 2026 ASCO Annual Meeting

21-04-2026

yahoo.com

Moleculin’s Annamycin Extends Survival by More Than 60% in Metastatic Pancreatic Cancer Preclinical Models - Data Presented at AACR 2026

23-04-2026

yahoo.com

Moleculin Biotech Secures Strategic Additional Patent, Strengthening Global Positioning of Annamycin

08-05-2026

yahoo.com

Independent Cleveland Clinic Review Finds No Clinically Significant Cardiotoxicity with Moleculin's Annamycin in R/R AML Patients Dosed Beyond Conventional Anthracycline Limits

12-05-2026

yahoo.com

Moleculin Announces Imminent MIRACLE Trial Unblinding as Blinded Data Continue to Significantly Outperform Historical Benchmarks

13-05-2026

yahoo.com

Nano-Cap Moleculin Biotech Approaches Key Leukemia Trial Data Unblinding

13-05-2026

yahoo.com

Moleculin Reports First Quarter 2026 Financial Results and Provides Clinical Update on Pivotal MIRACLE Trial

15-05-2026

yahoo.com

Moleculin Highlights Abstract Accepted for Poster Presentation at the 2026 ASCO Annual Meeting Highlighting Cardiac Safety Data for Annamycin

21-05-2026

yahoo.com

MOLECULIN BIOTECH INC (MBRX:NASDAQ) Sentiment Trend

0 25 50 75 100 55 84 74 61 78 33 49 85 65 79 23-03-2026 07-04-2026 21-04-2026 23-04-2026 08-05-2026 12-05-2026 13-05-2026 15-05-2026 21-05-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

MOLECULIN BIOTECH INC (MBRX:NASDAQ) FAQs

toggle

What is the current price of MOLECULIN BIOTECH INC (MBRX:NASDAQ)?

The current price of MOLECULIN BIOTECH INC (MBRX:NASDAQ) is $2.73.


toggle

MOLECULIN BIOTECH INC (MBRX:NASDAQ) absolute price change since previous trading day?

The absolute price change of MOLECULIN BIOTECH INC (MBRX:NASDAQ) since the previous trading day is $0.28.


toggle

MOLECULIN BIOTECH INC (MBRX:NASDAQ) percentage price change since previous trading day?

The percentage price change of MOLECULIN BIOTECH INC (MBRX:NASDAQ) since the previous trading day is 11.4286%.


toggle

What is the most recent average sentiment score for MOLECULIN BIOTECH INC (MBRX:NASDAQ)?

The most recent average sentiment score for MOLECULIN BIOTECH INC (MBRX:NASDAQ) is 66 out of 100.


toggle

What is the most recent average sentiment for MOLECULIN BIOTECH INC (MBRX:NASDAQ)?

The most recent sentiment for MOLECULIN BIOTECH INC (MBRX:NASDAQ) is .


SEC-8K** Filing Available For MOLECULIN BIOTECH INC (MBRX:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.